TOULOUSE
Founder, CEO & CSO of Antellis. For more than 10 years Antellis (Contract laboratory / CRO) has developed know-how and experience in the field of ICP-MS / ICP-OES analysis (heavy metals, elemental impurities, metal based drugs, nanoparticles,…) for biotechs, cosmetic and pharmaceutical players. Two main activities:
- Quality control of raw materials, drugs substances, drug products, cosmetics: analytical method development and validation, determination of metal traces and elemental impurities, catalysts, according to ICH Q3D, USP 232, PE 5.20.
- Bioanalytical analyses: analytical method development and validation, metal determinations (metal based drugs, metal nanoparticles) for preclinical or clinical studies.
Mes compétences :
ICP-MS
Analytical method validation
ICH Q3D
USP < 232 < / < 233 >
